Movik, E., Hamidi, V., Natvig Norderhaug, I., & Klemp, M. (2009). Health economic analysis of bevacizumab + paclitaxel versus paclitaxel alone as first-line treatment for metastatic breast cancer. Oslo: Norwegian Knowledge Centre for the Health Services.
Chicago Style CitationMovik, Espen, Vida Hamidi, Inger Natvig Norderhaug, and Marianne Klemp. Health Economic Analysis of Bevacizumab + Paclitaxel Versus Paclitaxel Alone As First-line Treatment for Metastatic Breast Cancer. Oslo: Norwegian Knowledge Centre for the Health Services, 2009.
MLA CitationMovik, Espen, Vida Hamidi, Inger Natvig Norderhaug, and Marianne Klemp. Health Economic Analysis of Bevacizumab + Paclitaxel Versus Paclitaxel Alone As First-line Treatment for Metastatic Breast Cancer. Oslo: Norwegian Knowledge Centre for the Health Services, 2009.